|
GNL2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.141400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.231800E-01 |
| Normal-vs-Stage2 |
2.249200E-01 |
| Normal-vs-Stage3 |
7.486200E-01 |
| Normal-vs-Stage4 |
2.660200E-01 |
| Stage1-vs-Stage2 |
2.191600E-02 |
| Stage1-vs-Stage3 |
7.117600E-02 |
| Stage1-vs-Stage4 |
8.929000E-01 |
| Stage2-vs-Stage3 |
2.729000E-01 |
| Stage2-vs-Stage4 |
3.812300E-02 |
| Stage3-vs-Stage4 |
1.440630E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.835800E-01 |
| Normal-vs-AfricanAmerican |
9.015200E-01 |
| Normal-vs-Asian |
2.420600E-01 |
| Caucasian-vs-AfricanAmerican |
6.049000E-01 |
| Caucasian-vs-Asian |
6.480200E-01 |
| AfricanAmerican-vs-Asian |
4.519800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.660400E-01 |
| Normal-vs-Female |
6.416400E-01 |
| Male-vs-Female |
4.827400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.542500E-02 |
| Normal-vs-Age(41-60Yrs) |
5.563200E-01 |
| Normal-vs-Age(61-80Yrs) |
6.242200E-01 |
| Normal-vs-Age(81-100Yrs) |
2.345200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.939920E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.397540E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.093000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.517400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.802200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.070600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.117000E-01 |
| Classical-VS-Follicular |
9.59379997667043E-09 |
| Classical-VS-Other |
9.649600E-01 |
| Classical-VS-Normal |
6.034300E-02 |
| Tall-VS-Follicular |
3.862500E-02 |
| Tall-VS-Other |
5.710600E-01 |
| Tall-VS-Normal |
8.243200E-01 |
| Follicular-VS-Other |
1.052190E-01 |
| Follicular-VS-Normal |
1.169600E-02 |
| Other-VS-Normal |
4.332000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.639800E-01 |
| Normal-vs-N1 |
9.521800E-02 |
| N0-vs-N1 |
5.202700E-03 |
|
|
